Donor-Derived Second Generation of CD19 CAR-T Cell Therapy for Relapsed B-Cell Acute Lymphoblastic Leukemia after Allogenic Stem Cell Transplantation

被引:7
|
作者
Zhang, Rongli [1 ,2 ,3 ]
He, Yi [1 ,2 ,3 ]
Yang, Donglin [1 ,2 ,3 ]
Wang, Ying [2 ,4 ]
Feng, Sizhou [1 ,2 ,3 ]
Wang, Jianxiang [2 ,5 ]
Han, Ming-Zhe [1 ,2 ,3 ]
机构
[1] CAMS, Stem Cell Transplantat Ctr, Inst Hematol, Tianjin, Peoples R China
[2] CAMS, Hosp Blood Dis, Tianjin, Peoples R China
[3] PUMC, Tianjin, Peoples R China
[4] Chinese Acad Med Sci, Leukemia Ctr, Inst Hematol, Tianjin, Peoples R China
[5] Chinese Acad Med Sci, State Key Lab Expt Hematol, Inst Hematol, Tianjin, Peoples R China
关键词
donor-derived CD19 CAR-T cell therapy; allogenic stem cell transplantation; B cell acute lymphoblastic leukemia; relapse;
D O I
10.1182/blood-2018-99-114950
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
2179
引用
下载
收藏
页数:2
相关论文
共 50 条
  • [11] Multiple CAR-T cell therapy for acute B-cell lymphoblastic leukemia after hematopoietic stem cell transplantation: A case report
    Deng, Lei
    Yu, Xiaolin
    Wu, Qian
    Song, Xiaochen
    Li, Wenjun
    Hou, Yixi
    Liu, Yue
    Wang, Jing
    Tian, Jun
    Zuo, Xiaona
    Zhou, Fang
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [12] Role of CAR-T cell therapy in B-cell acute lymphoblastic leukemia
    Greinix, Hildegard T.
    MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY, 2020, 13 (01) : 36 - 42
  • [13] Role of CAR-T cell therapy in B-cell acute lymphoblastic leukemia
    Hildegard T. Greinix
    memo - Magazine of European Medical Oncology, 2020, 13 : 36 - 42
  • [14] Consolidative Hematopoietic Stem Cell Transplantation After CD19 CAR-T Cell Therapy for Acute Lymphoblastic Leukemia: A Systematic Review and Meta-analysis
    Xu, Xinjie
    Chen, Sifei
    Zhao, Zijing
    Xiao, Xinyi
    Huang, Shengkang
    Huo, Zhaochang
    Li, Yuhua
    Tu, Sanfang
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [15] CD19 CAR T-cell therapy in relapsed TCF3-HLF-positive B-cell acute lymphoblastic leukemia
    Yao, Yao
    Zhou, Jin
    Li, Yanting
    Shi, Sensen
    Yu, Lei
    Wu, Depei
    Wang, Ying
    ANNALS OF HEMATOLOGY, 2024, : 6031 - 6033
  • [16] Allogeneic CD19/CD22 CAR T-Cell Therapy for B-Cell Acute Lymphoblastic Leukemia
    Phely, Laurent
    Hensen, Luca
    Faul, Christoph
    Ruff, Christer Alexander
    Schneider, Dina
    Bethge, Wolfgang Andreas
    Lengerke, Claudia
    JAMA ONCOLOGY, 2024, 10 (06) : 789 - 792
  • [17] Secondary donor-derived CD19 CAR-T therapy is safe and efficacious in acute lymphoblastic leukemia with extramedullary relapse after first autologous CAR-T therapy
    Kong, Delin
    Yang, Tingting
    Geng, Jia
    Jing, Ruirui
    Zhang, Qiqi
    Wei, Guoqing
    Huang, He
    Hu, Yongxian
    JOURNAL OF ZHEJIANG UNIVERSITY-SCIENCE B, 2022, 23 (10): : 876 - 880
  • [18] Efficacy and Safety of the Second CAR-T Therapy in Patients with Refractory/Relapsed Acute B-Cell Lymphoblastic Leukemia
    Liu, Sining
    Cui, Qingya
    Li, Zheng
    Cui, Wei
    Li, Mengyun
    Qiu, Huiying
    Xue, Shengli
    Chen, Suning
    Jin, Zhengming
    Miao, Miao
    Han, Yue
    Wang, Ying
    Zhu, Xiaming
    Yu, Lei
    Wu, Depei
    Tang, Xiaowen
    BLOOD, 2023, 142
  • [20] CD19-Targeted CAR-T Cell Therapy for 32 B-Cell Acute Lymphoblastic Leukemia (B-ALL) PatientsWHO Relapsed After Allogeneic Hematopoietic Stem Cell Transplantation (ALLO-HSCT)
    Zhang, Xian
    Yang, Junfang
    Zhang, Jianping
    Li, Jingjing
    Li, Wenqian
    Lu, Peihua
    BONE MARROW TRANSPLANTATION, 2020, 55 (SUPPL 1) : 171 - 172